In an initial experiment, rabbits were injected i.v. with a platelet-activating factor (PAF) antagonist CV-3988 twice a day on days 5 and 6 of pregnancy. Some inhibition of implantation was observed. This effect could not be reproduced in subsequent experiments at the same or at larger or smaller doses. The non-metabolized analogue of PAF, N-carbamyl-PAF (C-PAF) had an inhibitory effect on implantation only when given at toxic concentrations. When CV-3988 and C-PAF were given together on days 5 and 6, there was no effect on implantation. None of the other PAF antagonists tested \p=n-\BN52021, SR163,441, WEB2086 or TCV-309 \p=n-\at various doses could inhibit implantation when given on the same days of pregnancy. TCV-309, at 0.1 mg kg\m=-\ i.v. given on days 2\p=n-\4 of pregnancy, was also ineffective. These results provide no clear support for a role of PAF in implantation in rabbits.
Introduction
Platelet-activating factor (PAF: l-0-alkyl-2-acetyl-srí-glycero-3-phosphorylcholine) is a potent lipid mediator, which is synthe¬ sized in many cells in response to inflammatory stimuli (Braquet et al, 1987;  Hanahan and Kumar, 1987; Pinckard et al, 1988) . It has been suggested that PAF is involved in many reproductive processes (Harper, 1989) . PAF is secreted from the zygotes of a variety of species, including mice, humans and sheep (O'Neill et al, 1985; Angle et al, 1988a; Collier et al, 1988 Collier et al, , 1990  Kodama et al, 1989; Adamson et al, 1991; Battye et al, 1991) , although other workers have reported that PAF is not secreted by zygotes (Amiel el al, 1989; Smal et al, 1990) . PAF is thought not to be secreted by unfertilized ova (O'Neill, 1987) , and secretion of PAF is a good indicator of the probability that a zygote will give rise to a pregnancy (O'Neill et al, 1985) , although this correlation is not absolute (Collier et al, 1990) . Both mouse and human embryos exposed to PAF in vitro give rise to a better implantation rate after transfer to a recipient than do those in the absence of PAF (O'Neill et al, 1989; Ryan et al, 1990) , and result in normal offspring (O'Neill el al, 1992) .
PAF receptors have been detected in rabbit oviduct membrane preparations (Yang et al, 1992) , and secreted embryonic PAF could exert biological actions through such receptors.
PAF has also been detected in uterine tissue of rats (Yasuda et al, 1986 (Yasuda et al, , 1988 Nakayama et al, 1987) , rabbits (Angle et al, 1988b) and humans (Alecozay et al, 1989 (Alecozay et al, , 1991 ). PAF appears to be located mainly in the endometrium in rabbits, and to increase rapidly during the first few days of pregnancy and pseudopregnancy (Angle et al, 1988b (Spinks and O'Neill, 1988) . However, Milligan and Finn (1990) found that PAF antagonists given i.p., but every hour for 24 h after induction of implantation by oestradiol administration in mice with delayed implantation, or once daily for 4 days to intact mice, did not inhibit implantation. Furthermore, PAF itself administered into the uterine lumen failed to induce a decidual reaction. In contrast, Ando et al. (1990a, b) showed that two PAF antagonists, given during early pregnancy, decreased litter sizes in mice. CV-6209 was found to be most effective when given on days 4 and 5 of pregnancy, and this was apparently a maternal effect, as implantation was suppressed when day 4 embryos from saline-treated donor mice were transferred to CV-6209-treated recipient mice. Once implanted, however, embryonic growth and development were normal (Ando et al, 1990b) . In addition, a PAF antagonist administered into the uterine lumen of rats inhibited implantation most effectively on day 4 (the day before implantation) (Acker et al, 1988) , and PAF itself administered into the lumen on day 5 of pseudopregnancy induced a deciduomal reaction, which could be inhibited by concomitant administration of a PAF antagonist (Acker et al, 1989 (Casals-Stenzel et al, 1987; Takatani et al, 1990) .
The (Hoffman et al, 1978) . This evidence implies that a temporary delay to the implantation process can occur in rabbits, but with indomethacin treatment subsequent fetal growth was also compromised (Hoffman, 1978 
